Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Exor is underwriting the entire capital increase
-
Paves the way for Saudi sovereign wealth fund to launch a giant follow-on of Aramco stock
-
Investors pile into the Greek state's clean-up sale of its entire 27% stake in Piraeus in Monday's fully marketed offering
-
The Swedish real estate sector has felt the pressure of rising borrowing costs
-
Lossmaking Swiss solar cell manufacturer is scaling back production in Europe, opening in US
-
Saudi Aramco follow-on could hit $20bn